Navigation Links
Hyperplasia in Medical News

Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms

WALTHAM, Mass., Aug. 3 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, from 2013 to 2018, generic erosion of established agents--most notably tamsulosin--will cause a decline of more than eig...

Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients

- Uniquely Selective Agent Offers Significant Improvement - CHICAGO , April 28 /PRNewswire-FirstCall/ -- Data to be presented at the American Urological Association's (AUA) Annual Conference show that RAPAFLO (TM) (silodosin) produces rapid and sustained improvements of both irritati...

World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)

New evidence from large-scale studies points to a relationship between erectile dysfunction and prostate enlargement. Because of this, J. Francois Eid, M.D. has decided to expand his practice to increase the treatment of BPH in men. The focus of Dr. Eid's practice, Advanced Urological Care, has p...

Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)

- RAPAFLO launch anticipated in early 2009 - CORONA, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved RAPAFLO(TM) (silodos...

HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product

KING OF PRUSSIA, Pa., June 25 /PRNewswire/ -- HighPoint Solutions LLC, a premier provider of business-driven IT solutions, announced today it has been selected to develop an Incentive Compensation Plan for a new Benign Prostatic Hyperplasia (BPH) product currently under FDA approval review. Wi...

Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs

Long-Term Outlook More Favorable as Drugs from Eli Lilly and GlaxoSmithKline Will Drive the Market in 2016, According to a New Report from Decision Resources WALTHAM, Mass., Sept. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advi...
Hyperplasia in Medical Technology

RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days

- Significant peak urine flow (Qmax) improvements within 2-6 hours of the first dose, according to published data - CORONA, Calif., May 8 /PRNewswire-FirstCall/ -- RAPAFLO (TM) (silodosin), a new, uniquely selective alpha blocker for the treatment of the signs and symptoms of BPH, produ...

Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)

-- New product, now available in pharmacies, will provide rapid symptom relief for number one reason men visit a urologist -- CORONA, Calif., April 7 /PRNewswire-FirstCall/ --Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that RA...

Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder

- Innovative pipeline products highlight Watson's commitment to urology - Embargoed Until 2:10 PM EDT ORLANDO, Fla., May 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that investigators p...

Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia

-- Data Presented at American Urological Association Annual Meeting -- SEATTLE and CHICAGO, April 28 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN ) today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small m...

Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia

- Data Presented at American Urological Association Annual Meeting - SEATTLE and ORLANDO, Fla., May 21 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN ) today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small...

Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia

CORONA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that its New Drug Application (NDA) for silodosin, a novel alpha(1)- adrenoreceptor antagonist, has been accepted for filing by the U.S. Foo...
Hyperplasia in Medical Products

Congenital Adrenal Hyperplasia

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Aldosterone RIA Test

Description:...evated renin secretion [3,6]. Abnormally low aldosterone secretion occurs in a number of conditions including salt-wasting forms of congenital adrenal hyperplasia and renin deficiency [4,7,8]. References 1. Crabb J. Mol Cell Endocrinol 90:C11-C13, 1992. 2. Morris DJ. Endocrin Rev 2:234-247, ...
Company:Diagnostic Systems Laboratories, Inc.

Androstanediol Glucuronide RIA Test

Description:...3alpha-diol G is derived from DHEA-Sulfate and androstenedione. Elevated levels of serum 3alpha-diol G have been reported in congenital adrenal hyperplasia [3,4] and in various forms of female hirsutism [1,5,6], e.g. idiopathic hirsutism and polycystic ovary disease. Serum 3alpha-diol G may be elevated in...
Company:Diagnostic Systems Laboratories, Inc.

Androstanediol Glucuronide EIA Test

Description:...3alpha-diol G is derived from DHEA-Sulfate and androstenedione. Elevated levels of serum 3alpha-diol G have been reported in congenital adrenal hyperplasia [3,4] and in various forms of female hirsutism [1,5,6], e.g. idiopathic hirsutism and polycystic ovary disease. Serum 3alpha-diol G may be elevated in...
Company:Diagnostic Systems Laboratories, Inc.

Androstenedione EIA Test

Description:...ostenedione provides a useful marker of androgen biosynthesis. Elevated androstenedione levels have been demonstrated in virilizing congenital adrenal hyperplasia [4]. Serum androstenedione levels are also increased in polycystic ovary syndrome, ovarian stromal hyperthecosis, 3b-hydroxysteroid dehydrogenase defi...
Company:Diagnostic Systems Laboratories, Inc.

Androstenedione RIA Test

Description:...ostenedione provides a useful marker of androgen biosynthesis. Elevated androstenedione levels have been demonstrated in virilizing congenital adrenal hyperplasia [4]. Serum androstenedione levels are also increased in polycystic ovary syndrome, ovarian stromal hyperthecosis, 3b-hydroxysteroid dehydrogenase defi...
Company:Diagnostic Systems Laboratories, Inc.
Hyperplasia in Medical Definition

Pathology

...e to chromosomes from radiation or chemicals. hyperplasia is a long-term adaptive response of cell divisio...he skin can cause a protective thickening due to hyperplasia of the epidermis . Hypertrophy is an increase i... Pseudo-Cushing's syndrome ) - Congenital adrenal hyperplasia ( due to 21-hydroxylase deficiency ) - Hyperaldo...
Hyperplasia in Medical Dictionary

Hyperplasia

Hyperplasia is a general term referring to the proliferation of cells within an organ or tissue beyond that which is ordinarily seen . Hyperplasia may result in the gross enlargement of an organ, the formation of a benign... Endometrial hyperplasia is a condition of excessive proli...

Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) also known as nodular hyperplasia , benign prostatic hypertrophy or benign enlargement of the prostate (BEP) refers to the increase in size of the prostate in middle-aged and elderly men. To... Get the facts on benign prostatic hyperplasia s...

Adrenal Hyperplasia

Congenital adrenal hyperplasia (CAH) refers to any of several autosomal recessive diseases resulting from mutations of genes for enzymes mediating the biochemical steps of production of cortisol from cholesterol by the... Congenital Adrenal Hyperplasia (304) 558-7256 or Toll-Fre...

Urinary hesitancy

...y hesitancy can be caused by: Benign prostatic hyperplasia ... Treatment of urinary hesitancy varies dep...y hesitancy can be caused by: Benign prostatic hyperplasia ... Treatment of urinary hesitancy varies dep...y hesitancy can be caused by: Benign prostatic hyperplasia ... Treatment of urinary hesitancy varies dep...

Transurethral resection of the prostate

...ostate is a urological operation. It is used to treat benign prostatic hyperplasia (BPH). As the name indicates, it is performed by visualising the prost...state (TURP) is surgery done to remove part of ... Benign Prostate hyperplasia (BPH) Blockages inside the Kidney. Blockages ... Transurethral electro- r...

Prostate Problems

...mples of non-cancer prostate problems : ... All men are at risk for prostate problems , which include prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis. Here's how to assess your odds and ... ... information on impotence, heart disease, prostate and colon cancers and ...
Hyperplasia in Biological News

First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal

...dwide are familial and present as an autosomal inherited disorder. In individuals with the inherited form of MTC, a preneoplastic lesion called C-cell hyperplasia will first develop and then progress to an invasive, life-threatening malignancy. The American Thyroid Association ( www.thyroid.org ) has compile...

A compound extracted from olives inhibits cancer cells growth and prevents their appearance

...ease inhibitor that, among other features, has the capacity of regulating cell growth. It is useful for cancer treatment, as it allows to control the hyperplasia and hypertrophy processes, typical of this disease . The scientists of the UGR have characterized for the first time maslinic acid action from the m...

Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds

... interpretation by multiplying it times two for these men." Finasteride was initially developed in the 1990s for the treatment of benign prostatic hyperplasia (BPH), better known as enlarged-prostate disease, and was first approved by the U.S. Food and Drug Administration for this use. Patients with BPH must...

Exposure to dioxins influences male reproductive system, study of Vietnam veterans concludes

...e prostate in humans like they do in animals." The researchers found that veterans exposed to dioxin had lower incidence rates of benign prostate hyperplasia (BPH), better known as enlarged-prostate disease. BPH is a disease in humans that is caused by an enlargement of the prostate. Patients must strain to...

A giant among minnows: Giant danio can keep growing

...rst phase of the study, the researchers found that hyperplasia accounts for 67 percent of the giant danio’s muscle growth, compared to the zebrafish in which hyperplasia accounts for only 47 percent of the growth. S...dult zebrafish did not exhibit increased growth or hyperplasia in response to growth hormone, suggesting that zeb...

Possible birthplace of malignant brain tumors identified

... cells and the early changes associated with tumor initiation, suggesting they may be targets of neoplastic transformation. The regression of atypical hyperplasia after PDGF removal described here suggests that inhibition of PDGF signaling could provide a useful therapy for those gliomas in which the pathway is ...
Hyperplasia in Biological Technology

AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

QUEBEC CITY, June 15 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that patient follow-up in the open-label safety study (study 041) of its Phase 3 program in benign prostatic...

More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Line Therapy

Less Than 20 Percent of Patients Diagnosed with the Disease Receive Pharmacotherapy Within a Year of Their Diagnosis, According to a New Report From Decision Resources WALTHAM, Mass., April 7, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research...

AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

QUEBEC CITY, June 10 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the opening of an extended study in the Phase 3 program with cetrorelix pamoate for the treatment of benign...

AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia

All amounts are in US dollars QUEBEC CITY, March 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the signing of a development, commercialization and licensing agreement ...

AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia

QUEBEC CITY, Oct. 1, /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported the completion of patient recruitment for the Company's second efficacy trial of its Phase 3 program in b...

AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia

QUEBEC CITY, April 22 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner, Spectrum Pharmaceuticals (NASDAQ: SPPI ), released Phase 2b results for ozarelix, a ...
Hyperplasia in Biological Definition

Cancer

...ometimes detect a condition called "hyperplasia". hyperplasia refers to tissue growth based on an excessive rat...ithin the tissue remain normal, and the process of hyperplasia is potentially reversible. hyperplasia can be a normal tissue response to an irritating s...
Hyperplasia in Biological Dictionary

Prostate gland

...atment options from the American Academy ... Since the prostate gland and the lymph nodes are not taken out, your doctor ... Benign prostatic hyperplasia is commonly known as an enlarged prostate gland . ... As a result, the prostate gland begins to press on the urethra like a clamp. ... ...

Gastrin

...ociated with the last five C-terminal residues. ... Gastrin ... and intestinal acidity rises, gastrin production normally decreases. ... G-cell hyperplasia (overactivity of gastrin -producing cells in the stomach) ... Gastrin is the major hormone that regulates acid secretion in the stomach. ......
Other Tags
(Date:7/11/2014)... The report “Probiotics Market by ... Feed), Applications (Regular, Therapeutic, Preventive Health Care) & ... Forecasts to 2019 ” defines and segments the ... of the market value of probiotic products and ... restraining factors for the global market with an ...
(Date:7/11/2014)... Global enterprises today are shifting towards the changing trend ... services offer these global enterprises a strategic method to ... rising operational costs to companies. The aim to minimize ... global market driver for expanding the managed services market ... is estimated to grow from $142.75 billion in 2013 ...
(Date:7/11/2014)... Toledo, Ohio (PRWEB) July 11, 2014 ... (Morgenson 7/10/14) and FiercePharma (Weintraub 7/11/14), a significant number ... in blood sugar, abdominal issues and even death from ... exposed. , According to the Times report , ... events in 2013 reported by patients was almost 14% ...
(Date:7/11/2014)... its kind has found that organic foods and ... conventional counterparts, including more antioxidants and fewer, less ... an unprecedented 343 peer-reviewed publications comparing the nutritional ... foods, including fruits, vegetables, and grains. The study ... between organic and non-organic foods. , "Science ...
(Date:7/11/2014)... HealthDay Reporter THURSDAY, July 10, 2014 ... the worldwide scourge of dengue fever was somewhat successful in ... prevented dengue fever in 56 percent of the 10,000 kids ... more than 88 percent of them from severe disease. In ... sometimes death. "This vaccine has already proven to be ...
Breaking Medicine News(10 mins):Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:Acthar’s Deadly Adverse Events Revealed 2Health News:Acthar’s Deadly Adverse Events Revealed 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3
(Date:7/11/2014)... Sweden, have explored two different ways that allow ... to the formation of oxygen molecules in photosynthesis. ... scientific journal Nature Communications . , "The ... catalysts for water oxidation, which are key components ... storage of solar energy in fuels like hydrogen, ...
(Date:7/11/2014)... demonstrated that transplantation of mesenchymal stem cells can stimulate ... models of Alzheimer,s disease (AD) and improve tissue and ... studies are reported on the therapeutic effect of adipose-derived ... on the effect on oxidative injury and neurogenesis in ... her team, School of Life Sciences, Tsinghua University, China ...
(Date:7/11/2014)... 1 can inhibit voltage-gated calcium channel, decrease ... However, some scholars demonstrated that cannabinoid receptor ... and increase neurotransmitter release. Dr. Yi Zhang ... Tongji Medical College, Huazhong University of Science ... and calcium imaging in cultured trigeminal ganglion ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2
Other Contents